123 related articles for article (PubMed ID: 6846246)
21. Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers.
Lee JS; Park S; Park JM; Cho JH; Kim SI; Park BW
Breast Cancer Res Treat; 2013 Oct; 141(3):477-84. PubMed ID: 24072270
[TBL] [Abstract][Full Text] [Related]
22. CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer.
Dnistrian AM; Schwartz MK; Greenberg EJ; Smith CA; Schwartz DC
Clin Chim Acta; 1991 Aug; 200(2-3):81-93. PubMed ID: 1777973
[TBL] [Abstract][Full Text] [Related]
23. Carcinoembryonic antigen (CEA) measurements as an aid to management of patients with lung cancer treated by radiotherapy.
Ahlemann LM; Staab HJ; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):143-50. PubMed ID: 7279701
[TBL] [Abstract][Full Text] [Related]
24. Serial determinations of carcinoembryonic antigen for early detection of recurrent gastric cancer.
Tamada R; Hiramoto Y; Abe Y; Nouzuka T; Okamura T; Masuda H; Kano T; Kumashiro R; Inokuchi K
Jpn J Surg; 1982; 12(6):429-33. PubMed ID: 7166914
[TBL] [Abstract][Full Text] [Related]
25. C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients.
Molina R; Jo J; Filella X; Zanón G; Farrus B; Muñoz M; Latre ML; Pahisa J; Velasco M; Fernandez P; Estapé J; Ballesta AM
Anticancer Res; 1999; 19(4A):2551-5. PubMed ID: 10470193
[TBL] [Abstract][Full Text] [Related]
26. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
Paulick R; Caffier H; Paulick M
Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
[TBL] [Abstract][Full Text] [Related]
27. Relation between Carcinoembryonic Antigen Levels in Colon Cancer Tissue and Serum Carcinoembryonic Antigen Levels at Initial Surgery and Recurrence.
Saito G; Sadahiro S; Okada K; Tanaka A; Suzuki T; Kamijo A
Oncology; 2016; 91(2):85-9. PubMed ID: 27260164
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
Loprinzi CL; Tormey DC; Rasmussen P; Falkson G; Davis TE; Falkson HC; Chang AY
J Clin Oncol; 1986 Jan; 4(1):46-56. PubMed ID: 3510282
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
[TBL] [Abstract][Full Text] [Related]
30. Human tissue polypeptide antigen in breast cancer.
Nemoto T; Constantine R; Chu TM
J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
[TBL] [Abstract][Full Text] [Related]
31. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
32. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease.
Colomer R; Ruibal A; Salvador L
Cancer; 1989 Oct; 64(8):1674-81. PubMed ID: 2790682
[TBL] [Abstract][Full Text] [Related]
33. Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapy.
Falkson HC; Falkson G; Portugal MA; van der Watt JJ; Schoeman HS
Cancer; 1982 May; 49(9):1859-65. PubMed ID: 7074585
[TBL] [Abstract][Full Text] [Related]
34. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen.
Safi F; Kohler I; Röttinger E; Beger H
Cancer; 1991 Aug; 68(3):574-82. PubMed ID: 2065278
[TBL] [Abstract][Full Text] [Related]
35. Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer.
Mughal AW; Hortobagyi GN; Fritsche HA; Buzdar AU; Yap HY; Blumenschein GR
JAMA; 1983 Apr; 249(14):1881-6. PubMed ID: 6834584
[TBL] [Abstract][Full Text] [Related]
36. Value of serial carcinoembryonic antigen determinations for early detection of recurrent cancer.
Gray BN; Walker C; Barnard R
Med J Aust; 1981 Feb; 1(4):177-8. PubMed ID: 7231281
[TBL] [Abstract][Full Text] [Related]
37. [Carcinoembryonic antigen (CEA) in surgically treated cancer of the large intestine].
Metzger U; Decurtins M; Joller H; Grob PJ; Largiadèr F
Schweiz Med Wochenschr; 1983 Apr; 113(15):548-9. PubMed ID: 6857209
[TBL] [Abstract][Full Text] [Related]
38. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer.
Wood CB; Ratcliffe JG; Burt RW; Malcolm AJ; Blumgart LH
Br J Surg; 1980 Jan; 67(1):46-8. PubMed ID: 7357243
[TBL] [Abstract][Full Text] [Related]
39. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
[TBL] [Abstract][Full Text] [Related]
40. A statistical evaluation of baseline and follow-up carcinoembryonic antigen in patients with resectable colorectal carcinoma.
Lavin PT; Day J; Holyoke ED; Mittelman A; Chu TM
Cancer; 1981 Feb; 47(4):823-6. PubMed ID: 7226032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
